ENZO BIOCHEM INC Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q3 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Enzo Biochem Inc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q3 2019 to Q1 2024.
  • Enzo Biochem Inc Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending April 30, 2024 was $886K, a 79.2% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $886K -$3.37M -79.2% Apr 30, 2024 10-Q 2024-06-13
Q4 2023 $886K -$2.99M -77.1% Jan 31, 2024 10-Q 2024-03-13
Q3 2023 $896K -$2.98M -76.9% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 $895K -$2.94M -76.7% Jul 31, 2023 10-K 2023-11-03
Q1 2023 $4.25M +$519K +13.9% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $3.87M +$285K +7.94% Jan 31, 2023 10-Q 2023-03-20
Q3 2022 $3.87M +$312K +8.76% Oct 31, 2022 10-Q 2022-12-12
Q2 2022 $3.84M +$289K +8.15% Jul 31, 2022 10-K 2022-10-14
Q1 2022 $3.74M Apr 30, 2022 10-Q 2022-06-09
Q4 2021 $3.59M -$428K -10.7% Jan 31, 2022 10-Q 2022-03-14
Q3 2021 $3.56M -$371K -9.43% Oct 31, 2021 10-Q 2021-12-15
Q2 2021 $3.55M -$470K -11.7% Jul 31, 2021 10-K 2021-10-12
Q4 2020 $4.02M -$980K -19.6% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 $3.93M -$1.06M -21.3% Oct 31, 2020 10-Q 2020-12-11
Q2 2020 $4.02M Jul 31, 2020 10-Q 2021-06-11
Q1 2020 $5M Apr 30, 2020 10-Q 2020-06-09
Q4 2019 $5M Jan 31, 2020 10-Q 2020-03-06
Q3 2019 $5M Oct 31, 2019 10-Q 2019-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.